Financial Statements 2023

4. Notes to the IFRS Company Financial Statements 4.3 Operational Assets and Liabilities

4.3 Operational Assets and Liabilities

10.

Investments in Subsidiaries, Associates and Participations

(In € million)

Subsidiaries

Associates Participations

Total

Balance at 1 January 2022

16,309

49

977

17,334

Additions

2,369

0

5

2,374

Disposals

(18)

0

0

(18)

Impairment

0

0

0

0

Share ‑ based payment (IFRS 2)

115

0

0

115

Fair value changes through Profit or Loss

0

0

464

464

Balance at 31 December 2022

18,775

49

1,446

20,270

Additions

791

0

0

791

Disposals

(1,228)

0

0

(1,228)

Impairment

(19)

0

0

(19)

Share ‑ based payment (IFRS 2)

168

0

0

168

(1)

Fair value changes through Profit or Loss

0

0

163

163

Balance at 31 December 2023

18,487

49

1,609

20,145

For more details, please refer to “– Note 21: Other Investments and Other Long ‑ Term Financial Assets” of the Consolidated Financial Statements. (1)

Investments in Subsidiaries, Associated Companies and Participations

Investments in subsidiaries and associated companies are stated at cost, less impairment. Dividend income from the Company’s subsidiaries and associated companies is recognised when the right to receive payment is established. The participations are stated at fair value with mainly changes in fair value recognised in Profit and Loss. For the purpose of impairment testing all consolidated subsidiaries are allocated to cash generating units (“CGU”) in a way they are monitored for internal management purposes. At each balance sheet date, the Company reviews whether there is an indication that a CGU to which its investments in subsidiaries and associated companies belong to are impaired. An indication for impairment of the investments in subsidiaries and associated companies may include, respectively, management’s downward adjustment of the strategic plan, a significant decrease in the share price of a publicly listed

company or a significant decrease in future sales. Further indications for impairment of its investments may include other areas where observable data indicates that there is a measurable decrease in the estimated future cash flows. These determinations require significant judgement. In making this judgement, management evaluates, among other factors, the financial performance of and business outlook for its investments, including factors such as industry and sector performance, changes in technology and operational and financing cash flow. If any indication for impairment exists, the recoverable amount of the investments is estimated in order to determine the amount, if any, of the impairment loss. An investment is impaired if its recoverable amount is lower than its carrying value. The recoverable amount is defined as the higher of an investment’s fair value less costs of disposal and its value in use.

126

Airbus

Financial Statements 2023